|
EP1067910B1
(en)
|
1998-04-03 |
2004-05-26 |
Egalet A/S |
Controlled release composition
|
|
US6572890B2
(en)
*
|
2000-01-13 |
2003-06-03 |
Osmotica Corp. |
Osmotic device containing venlafaxine and an anti-psychotic agent
|
|
US6753011B2
(en)
*
|
2000-01-14 |
2004-06-22 |
Osmotica Corp |
Combined diffusion/osmotic pumping drug delivery system
|
|
US20020044962A1
(en)
*
|
2000-06-06 |
2002-04-18 |
Cherukuri S. Rao |
Encapsulation products for controlled or extended release
|
|
US7674480B2
(en)
*
|
2000-06-23 |
2010-03-09 |
Teva Pharmaceutical Industries Ltd. |
Rapidly expanding composition for gastric retention and controlled release of therapeutic agents, and dosage forms including the composition
|
|
US20060099245A1
(en)
*
|
2000-08-01 |
2006-05-11 |
Manoj Kumar |
Hydrodynamically balancing oral drug delivery system with biphasic release
|
|
JP4633329B2
(ja)
*
|
2001-01-12 |
2011-02-16 |
サン・ファーマ・アドバンスド・リサーチ・カンパニー・リミテッド |
スペーストドラッグデリバリーシステム
|
|
US6544927B2
(en)
*
|
2001-04-28 |
2003-04-08 |
University Of Florida |
Use of α2-adrenergic receptor agonists and adrenergic inhibitors in reducing defoliation
|
|
EP1377276B1
(en)
*
|
2001-04-10 |
2011-10-05 |
Sun Pharma Advanced Research Company Limited |
Timed pulse release composition
|
|
IN191028B
(pt)
*
|
2001-05-17 |
2003-09-13 |
Sun Pharmaceutical Ind Ltd |
|
|
US20030068375A1
(en)
|
2001-08-06 |
2003-04-10 |
Curtis Wright |
Pharmaceutical formulation containing gelling agent
|
|
US20050244498A1
(en)
*
|
2001-09-14 |
2005-11-03 |
Biovail Laboratories, Inc. |
Modified-release compositions of at least one form of venlafaxine
|
|
CA2460334A1
(en)
|
2001-09-14 |
2003-03-27 |
Francis J. Martin |
Microfabricated nanopore device for sustained release of therapeutic agent
|
|
WO2003024430A1
(en)
|
2001-09-21 |
2003-03-27 |
Egalet A/S |
Morphine polymer release system
|
|
WO2003024429A1
(en)
|
2001-09-21 |
2003-03-27 |
Egalet A/S |
Polymer release system
|
|
US20030073961A1
(en)
*
|
2001-09-28 |
2003-04-17 |
Happ Dorrie M. |
Medical device containing light-protected therapeutic agent and a method for fabricating thereof
|
|
WO2003030920A1
(en)
*
|
2001-10-08 |
2003-04-17 |
Sun Pharmaceutical Industries Limited |
An antispasmodic agent spaced drug delivery system
|
|
TW200302748A
(en)
*
|
2002-02-01 |
2003-08-16 |
Pfizer Prod Inc |
Osmotic delivery system
|
|
AR040301A1
(es)
*
|
2002-06-28 |
2005-03-23 |
Alza Corp |
Composicion osmotica expansible y suspension para revestimiento mejoradas
|
|
US20050208132A1
(en)
*
|
2002-07-29 |
2005-09-22 |
Gayatri Sathyan |
Methods and dosage forms for reducing side effects of benzisozazole derivatives
|
|
US20050232995A1
(en)
*
|
2002-07-29 |
2005-10-20 |
Yam Nyomi V |
Methods and dosage forms for controlled delivery of paliperidone and risperidone
|
|
US20040086566A1
(en)
*
|
2002-11-04 |
2004-05-06 |
Alpharma, Inc. |
Waxy matrix dosage forms
|
|
WO2004041252A1
(en)
|
2002-11-08 |
2004-05-21 |
Egalet A/S |
Controlled release carvedilol compositions
|
|
PL377479A1
(pl)
*
|
2002-12-11 |
2006-02-06 |
Pfizer Products Inc. |
Kontrolowane uwalnianie substancji czynnej do środowiska o wysokiej zawartości tłuszczu
|
|
US20070077301A1
(en)
*
|
2002-12-23 |
2007-04-05 |
Meyer Glenn A |
Venlafaxine osmotic device formulation
|
|
AR042550A1
(es)
*
|
2002-12-23 |
2005-06-22 |
Osmotica Argentina S A |
Una forma de dosificacion farmaceutica que comprende venlafaxina y memantina
|
|
US8293799B2
(en)
*
|
2003-12-29 |
2012-10-23 |
Osmotica Keresleedelmo és Szolgáltató KFT |
Osmotic device containing a venlafaxine salt and a salt having an ion in common
|
|
WO2004066981A1
(en)
*
|
2003-01-29 |
2004-08-12 |
Sun Pharmaceutical Industries Limited |
Oral controlled release pharmaceutical composition containing metaxalone as active agent
|
|
US20040176465A1
(en)
*
|
2003-03-07 |
2004-09-09 |
Pawan Seth |
Solid compositions containing fluoxetine and a coating
|
|
ES2570454T3
(es)
|
2003-03-26 |
2016-05-18 |
Egalet Ltd |
Sistema de liberación controlada de morfina
|
|
EP1974726B1
(en)
|
2003-03-26 |
2010-01-13 |
Egalet A/S |
Matrix compositions for controlled delivery of drug substances
|
|
US20060210633A1
(en)
*
|
2003-04-03 |
2006-09-21 |
Sun Pharmaceutical Industries Limited |
Programmed drug delivery system
|
|
IN2003MU00504A
(pt)
*
|
2003-06-05 |
2005-05-13 |
Alembic Ltd |
|
|
KR100601249B1
(ko)
*
|
2003-08-21 |
2006-07-13 |
한국화학연구원 |
경구용 약물 전달 기구용 서방형 다공성 막 형성 조성물
|
|
WO2004112746A1
(en)
*
|
2003-06-26 |
2004-12-29 |
Korea Research Institute Of Chemical Technology |
Controlled release-drug delivery system for oral administration
|
|
RS20060132A
(en)
*
|
2003-08-08 |
2008-06-05 |
Biovail Laboratories International Srl., |
Modified-release tablet of bupropion hydrochloride
|
|
WO2005020929A2
(en)
*
|
2003-09-02 |
2005-03-10 |
Imran Ahmed |
Sustained release dosage forms of ziprasidone
|
|
US7611728B2
(en)
*
|
2003-09-05 |
2009-11-03 |
Supernus Pharmaceuticals, Inc. |
Osmotic delivery of therapeutic compounds by solubility enhancement
|
|
US7470435B2
(en)
*
|
2003-11-17 |
2008-12-30 |
Andrx Pharmaceuticals, Llc |
Extended release venlafaxine formulation
|
|
US20050175695A1
(en)
|
2003-11-25 |
2005-08-11 |
Catherine Castan |
Carvedilol free base, salts, anhydrous forms or solvates thereof, corresponding pharmaceutical compositions, controlled release formulations, and treatment or delivery methods
|
|
WO2005051325A2
(en)
*
|
2003-11-25 |
2005-06-09 |
Sb Pharmco Puerto Rico Inc. |
Carvedilol compositions methods of treatment and delivery
|
|
US7201920B2
(en)
|
2003-11-26 |
2007-04-10 |
Acura Pharmaceuticals, Inc. |
Methods and compositions for deterring abuse of opioid containing dosage forms
|
|
US20050129764A1
(en)
*
|
2003-12-11 |
2005-06-16 |
Vergez Juan A. |
Osmotic device containing licofelone
|
|
ES2271714T3
(es)
*
|
2004-02-20 |
2007-04-16 |
Cum Pharma Consulting Anstalt |
Composicion farmaceutica para aplicacion oral y procedimiento de preparacion de la misma.
|
|
TW200533391A
(en)
*
|
2004-03-25 |
2005-10-16 |
Sun Pharmaceutical Ind Ltd |
Gastric retention drug delivery system
|
|
EP1765292B1
(en)
|
2004-06-12 |
2017-10-04 |
Collegium Pharmaceutical, Inc. |
Abuse-deterrent drug formulations
|
|
US7713550B2
(en)
*
|
2004-06-15 |
2010-05-11 |
Andrx Corporation |
Controlled release sodium valproate formulation
|
|
US20080152595A1
(en)
*
|
2004-11-24 |
2008-06-26 |
Acura Pharmaceuticals, Inc. |
Methods and compositions for deterring abuse of orally administered pharmaceutical products
|
|
US20060177380A1
(en)
*
|
2004-11-24 |
2006-08-10 |
Acura Pharmaceuticals, Inc. |
Methods and compositions for deterring abuse of orally administered pharmaceutical products
|
|
US20070231268A1
(en)
*
|
2004-11-24 |
2007-10-04 |
Acura Pharmaceuticals, Inc. |
Methods and compositions for deterring abuse of orally administered pharmaceutical products
|
|
US20060110327A1
(en)
*
|
2004-11-24 |
2006-05-25 |
Acura Pharmaceuticals, Inc. |
Methods and compositions for deterring abuse of orally administered pharmaceutical products
|
|
AR053986A1
(es)
|
2004-12-03 |
2007-05-30 |
Osmotica Pharmaceutical Argent |
Dispositivo osmotico que contiene amantadina y una sal osmotica
|
|
NZ561375A
(en)
|
2005-06-27 |
2011-06-30 |
Biovail Lab Int Srl |
Bupropion hydrobromide, and crystalline forms, compositions, and uses of this compound
|
|
EP1912622A2
(en)
*
|
2005-08-04 |
2008-04-23 |
Alza Corporation |
Osmotic dosage forms comprising semipermeable membranes with polymer blends providing improved properties
|
|
US7855279B2
(en)
*
|
2005-09-27 |
2010-12-21 |
Amunix Operating, Inc. |
Unstructured recombinant polymers and uses thereof
|
|
US20090099031A1
(en)
*
|
2005-09-27 |
2009-04-16 |
Stemmer Willem P |
Genetic package and uses thereof
|
|
US7846445B2
(en)
*
|
2005-09-27 |
2010-12-07 |
Amunix Operating, Inc. |
Methods for production of unstructured recombinant polymers and uses thereof
|
|
AU2006294644A1
(en)
*
|
2005-09-27 |
2007-04-05 |
Amunix, Inc. |
Proteinaceous pharmaceuticals and uses thereof
|
|
EP1981525B1
(en)
*
|
2005-12-30 |
2015-01-21 |
Zensun (Shanghai) Science and Technology Limited |
Extended release of neuregulin for improved cardiac function
|
|
MX2008012009A
(es)
*
|
2006-03-20 |
2008-10-03 |
Duramed Pharmaceuticals Inc |
Anillos intravaginales comprimidos y flexibles, metodos de elaboracion y utilizacion de los mismos y apaato de elaboracion de los mismos.
|
|
US20080081067A1
(en)
*
|
2006-10-03 |
2008-04-03 |
Gupta Manishkumar |
Sustained release pharmaceutical compositions of venlafaxine and process for preparation thereof
|
|
WO2008148798A2
(en)
|
2007-06-04 |
2008-12-11 |
Egalet A/S |
Controlled release pharmaceutical compositions for prolonged effect
|
|
US20090004281A1
(en)
*
|
2007-06-26 |
2009-01-01 |
Biovail Laboratories International S.R.L. |
Multiparticulate osmotic delivery system
|
|
EP2185701A4
(en)
*
|
2007-08-15 |
2011-03-02 |
Amunix Operating Inc |
COMPOSITIONS AND METHODS FOR ENHANCING THE PRODUCTION OF RECOMBINANT POLYPEPTIDES
|
|
MX2008003230A
(es)
*
|
2008-03-07 |
2009-09-07 |
Senosiain S A De C V Lab |
Composicion famaceutica oral que comprende la combinacion de una sal de ketorolaco y vitaminas del complejo b.
|
|
WO2010015840A1
(en)
*
|
2008-08-08 |
2010-02-11 |
Cipla Limited |
Osmotic delivery device with modified release
|
|
US8716448B2
(en)
|
2009-02-03 |
2014-05-06 |
Amunix Operating Inc. |
Coagulation factor VII compositions and methods of making and using same
|
|
NZ628987A
(en)
|
2009-02-03 |
2015-11-27 |
Amunix Operating Inc |
Extended recombinant polypeptides and compositions comprising same
|
|
EP2393484A1
(en)
|
2009-02-06 |
2011-12-14 |
Egalet Ltd. |
Immediate release composition resistant to abuse by intake of alcohol
|
|
CN102481331B
(zh)
|
2009-06-08 |
2017-09-22 |
阿穆尼克斯运营公司 |
葡萄糖调节多肽及其制备和使用方法
|
|
NZ621868A
(en)
|
2009-06-08 |
2015-10-30 |
Amunix Operating Inc |
Growth hormone polypeptides and methods of making and using same
|
|
AU2010265213B2
(en)
|
2009-06-24 |
2012-08-23 |
Egalet Ltd. |
Controlled release formulations
|
|
WO2011041414A1
(en)
|
2009-09-30 |
2011-04-07 |
Acura Pharmaceuticals, Inc. |
Methods and compositions for deterring abuse
|
|
US10668060B2
(en)
|
2009-12-10 |
2020-06-02 |
Collegium Pharmaceutical, Inc. |
Tamper-resistant pharmaceutical compositions of opioids and other drugs
|
|
BR112012022363A2
(pt)
|
2010-03-04 |
2016-07-05 |
Wockhardt Ltd |
forma de dosagem com liberação modificada
|
|
US9173389B2
(en)
|
2010-11-18 |
2015-11-03 |
Auburn University |
Systems and methods to deliver and maintain volatile compounds
|
|
US9185897B2
(en)
|
2010-11-18 |
2015-11-17 |
Auburn University |
Methods to deliver and maintain volatile compounds
|
|
AP3815A
(en)
|
2010-12-22 |
2016-09-30 |
Purdue Pharma Lp |
Encased tamper resistant controlled release dosage forms
|
|
BR112013015939A2
(pt)
|
2010-12-23 |
2020-08-04 |
Purdue Pharma L.P. |
formas farmacêuticas orais sólidas resistentes à adulteração
|
|
PT3564260T
(pt)
|
2012-02-15 |
2023-01-18 |
Bioverativ Therapeutics Inc |
Composições de fator viii e métodos de produção e utilização das mesmas
|
|
KR20190094480A
(ko)
|
2012-02-15 |
2019-08-13 |
바이오버라티브 테라퓨틱스 인크. |
재조합 인자 viii 단백질
|
|
BR112015000150A2
(pt)
|
2012-07-06 |
2017-06-27 |
Egalet Ltd |
composições farmacêuticas dissuasoras de abuso de liberação controlada
|
|
CN107595793B
(zh)
|
2012-11-30 |
2020-11-13 |
阿库拉制药公司 |
活性药物成分的自调节释放
|
|
JP6208261B2
(ja)
|
2013-02-05 |
2017-10-04 |
パーデュー、ファーマ、リミテッド、パートナーシップＰｕｒｄｕｅ Ｐｈａｒｍａ Ｌ．Ｐ． |
タンパリング抵抗性医薬製剤
|
|
US10751287B2
(en)
|
2013-03-15 |
2020-08-25 |
Purdue Pharma L.P. |
Tamper resistant pharmaceutical formulations
|
|
TWI667255B
(zh)
|
2013-08-14 |
2019-08-01 |
美商生物化學醫療公司 |
因子ｖｉｉｉ－ｘｔｅｎ融合物及其用途
|
|
CA2943728C
(en)
|
2014-03-26 |
2020-03-24 |
Sun Pharma Advanced Research Company Ltd. |
Abuse deterrent immediate release biphasic matrix solid dosage form
|
|
WO2017024060A1
(en)
|
2015-08-03 |
2017-02-09 |
Biogen Ma Inc. |
Factor ix fusion proteins and methods of making and using same
|
|
WO2017040607A1
(en)
|
2015-08-31 |
2017-03-09 |
Acura Pharmaceuticals, Inc. |
Methods and compositions for self-regulated release of active pharmaceutical ingredient
|
|
WO2017222575A1
(en)
|
2016-06-23 |
2017-12-28 |
Collegium Pharmaceutical, Inc. |
Process of making more stable abuse-deterrent oral formulations
|
|
WO2018002673A1
(en)
|
2016-07-01 |
2018-01-04 |
N4 Pharma Uk Limited |
Novel formulations of angiotensin ii receptor antagonists
|
|
US10213393B1
(en)
|
2018-02-15 |
2019-02-26 |
Osmotica Kereskedelmi és Szolgáltató Korlátolt Feleõsségû Társaság |
Composition and method for treating neurological disease
|
|
US20190247331A1
(en)
|
2018-02-15 |
2019-08-15 |
Osmotica Kereskedelmi és Szolgáltató Korlátolt Felelõsségû Társaság |
Composition and method for treating neurological disease
|
|
US10213394B1
(en)
|
2018-02-15 |
2019-02-26 |
Osmotica Kereskedelmi és Szolgáltató Korlátolt Felelõsségû Társaság |
Composition and method for treating neurological disease
|